Skip to main content
. 2016 Jun 9;18(6):356–370. doi: 10.1016/j.neo.2016.04.008

Table 2.

GSEA Analysis of miRNA Targeting in PCa

Comparison Gene Sets NES NOM P val FDR Q val
Castrate-resistant vs castrate–sensitive cells HALLMARK_E2F_TARGETS 1.85 .00 .02
HALLMARK_G2M_CHECKPOINT 1.81 .00 .02
HALLMARK_MYC_TARGETS_V2 1.38 .05 .29
HALLMARK_MYC_TARGETS_V1 1.35 .11 .26
AR-negative vs AR-positive cells HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION 2.18 .00 .01
HALLMARK_GLYCOLYSIS 1.94 .00 .01
HALLMARK_INTERFERON_GAMMA_RESPONSE 1.91 .00 .01
HALLMARK_HYPOXIA 1.87 .00 .01
HALLMARK_INTERFERON_ALPHA_RESPONSE 1.83 .03 .01
HALLMARK_INFLAMMATORY_RESPONSE 1.72 .00 .03
HALLMARK_IL6_JAK_STAT3_SIGNALING 1.70 .00 .03
HALLMARK_IL2_STAT5_SIGNALING 1.68 .00 .03
HALLMARK_APICAL_JUNCTION 1.65 .00 .04
HALLMARK_ALLOGRAFT_REJECTION 1.63 .00 .04
HALLMARK_UV_RESPONSE_DN 1.60 .03 .04
HALLMARK_COMPLEMENT 1.60 .02 .04
HALLMARK_ESTROGEN_RESPONSE_EARLY 1.56 .00 .05
HALLMARK_REACTIVE_OXIGEN_SPECIES_PATHWAY 1.54 .01 .06
HALLMARK_APOPTOSIS 1.51 .04 .07
HALLMARK_COAGULATION 1.51 .08 .07
HALLMARK_ESTROGEN_RESPONSE_LATE 1.47 .01 .08
HALLMARK_TNFA_SIGNALING_VIA_NFKB 1.45 .00 .09
HALLMARK_MITOTIC_SPINDLE 1.44 .04 .09
HALLMARK_WNT_BETA_CATENIN_SIGNALING 1.37 .08 .13
HALLMARK_MYOGENESIS 1.36 .11 .14
HALLMARK_PROTEIN_SECRETION 1.32 .07 .18
HALLMARK_MTORC1_SIGNALING 1.31 .14 .17
HALLMARK_PI3K_AKT_MTOR_SIGNALING 1.29 .08 .19
HALLMARK_TGF_BETA_SIGNALING 1.25 .20 .22
HALLMARK_MYC_TARGETS_V2 1.24 .16 .22
HALLMARK_XENOBIOTIC_METABOLISM 1.22 .16 .24
PCa vs other cancer cells HALLMARK_OXIDATIVE_PHOSPHORYLATION 1.66 .01 .21
LNCaP vs LNCaP-MDV3100 HALLMARK_P53_PATHWAY 1.81 .01 .02
HALLMARK_TNFA_SIGNALING_VIA_NFKB 1.49 .06 .10
HALLMARK_MTORC1_SIGNALING 1.34 .12 .15
HALLMARK_MYC_TARGETS_V1 1.22 .21 .21

NES indicates normalized enrichment score; FDR, false discovery rate. The P value represents a normal distribution.